Recalls & Warnings April 26, 2013 Seller of Immune, Cholesterol, Liver and Blood Sugar Products Warned For Drug Claims On March 20, 2013, the FDA issued a warning letter to Birkdale Medicinals LLC, following a review of the company's website which found statements made about Birkdale products, including Immune Response 247, Cholestat, Silymarin 81 and LevelStat, to be drug claims
Phenotype Considerations Perimenopausal users
One shot, longer effect, just like GLP-1s
Why Combine BPC-157 and TB-500 Instead of Running One Alone
Sony Sherpa holds a medical degree (MBBS, MD) and writes on peptide characterisation, chemical and structural data, and laboratory handling and storage